RE:RE:AstraZeneca's ADC disappoints - on severe adverse eventsApril 05, 2024 - Astrazeneca is planning to take steps to transform cancer outcomes by attacking cancers from multiple angles. As such, their plan is to develop a portfolio that spans multiple scientific platforms, with different modalities and mechanisms to kill cancer cells directly or activate the immune system against cancer:
https://www.astrazeneca.com/media-centre/articles/2024/oncology-r-and-d-strategy-driving-innovation.html